Company intelligence / Profile preview

Synbio Technologies

Monmouth Junction, New Jersey, United Statessynbio-tech.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Synbio Technologies is an active global leader in synthetic biology services. It offers advanced solutions such as custom gene/DNA/RNA/oligo synthesis, protein expression across multiple systems, CRISPR libraries/gene editing tools, antibody discovery/humanization services, and peptide production. The company’s technologies support applications from basic research to diagnostics to drug development for academic institutions and biopharma companies worldwide. It operates state-of-the-art facilities certified under ISO 9001 & ISO 13485 standards.

Therapeutic areas: Other
Modalities: Recombinant proteinAntibodyPeptidesRNA therapyDNA synthesisOligonucleotide synthesis
Industry: Drug Discovery Services

Partnerships

SnapGene

Beyond the preview

Go deeper on Synbio Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synbio Technologies.

Explore the full profile